These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 15565299

  • 21. Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes.
    Yasui-Furukori N, Mihara K, Takahata T, Suzuki A, Nakagami T, De Vries R, Tateishi T, Kondo T, Kaneko S.
    Br J Clin Pharmacol; 2004 May; 57(5):569-75. PubMed ID: 15089809
    [Abstract] [Full Text] [Related]

  • 22. Risperidone metabolism in relation to CYP2D6*10 allele in Korean schizophrenic patients.
    Roh HK, Kim CE, Chung WG, Park CS, Svensson JO, Bertilsson L.
    Eur J Clin Pharmacol; 2001 Nov; 57(9):671-5. PubMed ID: 11791898
    [Abstract] [Full Text] [Related]

  • 23. Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels.
    Lane HY, Chiu WC, Chou JC, Wu ST, Su MH, Chang WH.
    J Clin Psychiatry; 2000 Mar; 61(3):209-14. PubMed ID: 10817107
    [Abstract] [Full Text] [Related]

  • 24. Plasma risperidone concentrations during combined treatment with sertraline.
    Spina E, D'Arrigo C, Migliardi G, Morgante L, Zoccali R, Ancione M, Madia A.
    Ther Drug Monit; 2004 Aug; 26(4):386-90. PubMed ID: 15257068
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics and bioequivalence evaluation of risperidone in healthy male subjects with different CYP2D6 genotypes.
    Cho HY, Lee YB.
    Arch Pharm Res; 2006 Jun; 29(6):525-33. PubMed ID: 16833023
    [Abstract] [Full Text] [Related]

  • 26. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK, Zalar B, Breskvar K, Dolzan V.
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [Abstract] [Full Text] [Related]

  • 27. ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone.
    Ganoci L, Trkulja V, Živković M, Božina T, Šagud M, Lovrić M, Božina N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan 10; 104():110042. PubMed ID: 32682874
    [Abstract] [Full Text] [Related]

  • 28. Physiologically Based Pharmacokinetic Modelling to Describe the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone According to Cytochrome P450 2D6 Phenotypes.
    Kneller LA, Abad-Santos F, Hempel G.
    Clin Pharmacokinet; 2020 Jan 10; 59(1):51-65. PubMed ID: 31359271
    [Abstract] [Full Text] [Related]

  • 29. Effects of the CYP2D6*10 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia.
    Yagihashi T, Mizuno M, Chino B, Sato Y, Sakuma K, Takebayashi T, Takao T, Kosaki K.
    Hum Psychopharmacol; 2009 Jun 10; 24(4):301-8. PubMed ID: 19387994
    [Abstract] [Full Text] [Related]

  • 30. Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients.
    Saito M, Yasui-Furukori N, Nakagami T, Furukori H, Kaneko S.
    J Clin Psychopharmacol; 2005 Dec 10; 25(6):527-32. PubMed ID: 16282832
    [Abstract] [Full Text] [Related]

  • 31. Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients.
    Yasui-Furukori N, Saito M, Nakagami T, Furukori H, Suzuki A, Kondo T, Kaneko S.
    J Psychopharmacol; 2010 Jul 10; 24(7):987-94. PubMed ID: 19477882
    [Abstract] [Full Text] [Related]

  • 32. The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.
    van der Weide K, van der Weide J.
    J Clin Psychopharmacol; 2015 Jun 10; 35(3):228-36. PubMed ID: 25868121
    [Abstract] [Full Text] [Related]

  • 33. Metabolism of risperidone by CYP2D6 and the presence of drug-induced dopamine supersensitivity psychosis in patients with schizophrenia.
    Kanahara N, Yoshimura K, Nakamura M, Oda Y, Watanabe M, Iyo M.
    Int Clin Psychopharmacol; 2019 May 10; 34(3):124-130. PubMed ID: 30870237
    [Abstract] [Full Text] [Related]

  • 34. Serum concentrations of paliperidone versus risperidone and clinical effects.
    Nazirizadeh Y, Vogel F, Bader W, Haen E, Pfuhlmann B, Gründer G, Paulzen M, Schwarz M, Zernig G, Hiemke C.
    Eur J Clin Pharmacol; 2010 Aug 10; 66(8):797-803. PubMed ID: 20358189
    [Abstract] [Full Text] [Related]

  • 35. QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations.
    Llerena A, Berecz R, Dorado P, de la Rubia A.
    J Psychopharmacol; 2004 Jun 10; 18(2):189-93. PubMed ID: 15260906
    [Abstract] [Full Text] [Related]

  • 36. Impact of the ABCB1 gene polymorphism on plasma 9-hydroxyrisperidone and active moiety levels in Japanese patients with schizophrenia.
    Suzuki Y, Tsuneyama N, Fukui N, Sugai T, Watanabe J, Ono S, Saito M, Someya T.
    J Clin Psychopharmacol; 2013 Jun 10; 33(3):411-4. PubMed ID: 23609388
    [Abstract] [Full Text] [Related]

  • 37. Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone.
    Yasui-Furukori N, Tsuchimine S, Saito M, Nakagami T, Sugawara N, Fujii A, Kaneko S.
    J Clin Psychopharmacol; 2011 Oct 10; 31(5):633-7. PubMed ID: 21869689
    [Abstract] [Full Text] [Related]

  • 38. Exposure-response analysis after subcutaneous administration of RBP-7000, a once-a-month long-acting Atrigel formulation of risperidone.
    Ivaturi V, Gopalakrishnan M, Gobburu JVS, Zhang W, Liu Y, Heidbreder C, Laffont CM.
    Br J Clin Pharmacol; 2017 Jul 10; 83(7):1476-1498. PubMed ID: 28133766
    [Abstract] [Full Text] [Related]

  • 39. Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions.
    LLerena A, Berecz R, Dorado P, de la Garza CS, Norberto MJ, Cáceres M, Gutiérrez JR.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan 05; 783(1):213-9. PubMed ID: 12450541
    [Abstract] [Full Text] [Related]

  • 40. Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort.
    Vandenberghe F, Guidi M, Choong E, von Gunten A, Conus P, Csajka C, Eap CB.
    Clin Pharmacokinet; 2015 Dec 05; 54(12):1259-72. PubMed ID: 26129906
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.